Eikon Therapeutics Funding: $148M Raised, Series A (2026)
Eikon Therapeutics is a Biotech company based in California. It has raised $148M in total funding. Latest round: Series A.
Eikon Therapeutics funding overview
Eikon Therapeutics is a Biotech company based in California. Eikon Therapeutics has raised $148M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2026. The round record for Eikon Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital. 4 distinct backers are named across the disclosed rounds.
Eikon Therapeutics at a glance
Total raised
$148M
Latest round
Series A
Latest round date
February 2026
Industry
Biotech
Headquarters
California
Notable investors
The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital
Frequently asked about Eikon Therapeutics funding
How much has Eikon Therapeutics raised?
Eikon Therapeutics has raised $148M in total disclosed funding across the rounds on record.
Who has invested in Eikon Therapeutics?
The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital are named among the investors backing Eikon Therapeutics.
What was the latest Eikon Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2026.
Where is Eikon Therapeutics based?
Eikon Therapeutics is based in California.
What sector does Eikon Therapeutics operate in?
Eikon Therapeutics is tracked under Biotech from California, with $148M in disclosed funding.
When did Eikon Therapeutics last raise?
The last disclosed Eikon Therapeutics round closed in February 2026 at Series A.
We update the Eikon Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in California and their backers are listed below.
